Correlation Between Ionis Pharmaceuticals and International Growth

Can any of the company-specific risk be diversified away by investing in both Ionis Pharmaceuticals and International Growth at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ionis Pharmaceuticals and International Growth into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ionis Pharmaceuticals and International Growth Fund, you can compare the effects of market volatilities on Ionis Pharmaceuticals and International Growth and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ionis Pharmaceuticals with a short position of International Growth. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ionis Pharmaceuticals and International Growth.

Diversification Opportunities for Ionis Pharmaceuticals and International Growth

0.0

Correlation Coefficient

Ionis Pharmaceuticals  International Growth

Pay attention - limited upside

The 3 months correlation between Ionis and International is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Ionis Pharmaceuticals and International Growth Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on International Growth and Ionis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ionis Pharmaceuticals are associated (or correlated) with International Growth. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of International Growth has no effect on the direction of Ionis Pharmaceuticals i.e., Ionis Pharmaceuticals and International Growth go up and down completely randomly.

Pair Corralation between Ionis Pharmaceuticals and International Growth

Given the investment horizon of 90 days Ionis Pharmaceuticals is expected to under-perform the International Growth. In addition to that, Ionis Pharmaceuticals is 2.21 times more volatile than International Growth Fund. It trades about -0.15 of its total potential returns per unit of risk. International Growth Fund is currently generating about 0.02 per unit of volatility. If you would invest  1,257  in International Growth Fund on March 4, 2024 and sell it today you would earn a total of  9.00  from holding International Growth Fund or generate 0.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ionis Pharmaceuticals  vs.  International Growth Fund

Ionis Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ionis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in July 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

International Growth

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in International Growth Fund are ranked lower than 1 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong forward indicators, International Growth is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Ionis Pharmaceuticals and International Growth

The main advantage of trading using opposite Ionis Pharmaceuticals and International Growth positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ionis Pharmaceuticals position performs unexpectedly, International Growth can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in International Growth will offset losses from the drop in International Growth's long position.

The idea behind Ionis Pharmaceuticals and International Growth Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.